At Cytokinetics, corporate responsibility is a fundamental principle and incorporated into every aspect of our work advancing innovative medicines. We prioritize patient centricity, maintain a strong moral compass and a rigorous compliance program, and we uphold high standards for diversity, equity, inclusion, and respect. As we move toward commercialization and continued growth, we have a commitment to ensure equitable access and affordability of our medicines, and, as our carbon footprint expands, we are increasingly focused on supporting sustainable communities through responsible environmental practices.